Stober, Vandy P.
Lim, Yow-Pin
Opal, Steven
Zhuo, Lisheng
Kimata, Koji
Garantziotis, Stavros http://orcid.org/0000-0003-4007-375X
Funding for this research was provided by:
National Institute of Environmental Health Sciences (Z01ES102605)
National Institute of Allergy and Infectious Diseases (2R42AI062095)
Article History
Received: 19 February 2019
Accepted: 12 April 2019
First Online: 26 April 2019
Compliance with Ethical Standards
:
: Y-PL is the President and Chief Scientific Officer at ProThera Biologics, LLC, a company which explores the use of IαI in several systemic inflammatory diseases, including sepsis.